What is Inventiva Sa (IVA) stock price today?

Inventiva Sa (IVA) currently trades at $5.13 per share. The stock has a market capitalization of $1.07B and a P/E ratio of —x.

Is IVA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Inventiva Sa has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Inventiva Sa's revenue and earnings?

Inventiva Sa has trailing twelve-month (TTM) revenue of $6.76M with profit margins of 0.00%. Earnings per share (EPS) is $-2.23.

Is IVA stock overvalued or undervalued?

Based on our DCF model, Inventiva Sa's intrinsic value is $16.65, representing a margin of safety of 62.82%. The stock currently trades at a P/E of —x.

IVA

Inventiva Sa

NASDAQ: IVA · HEALTHCARE · BIOTECHNOLOGY

$5.13

+3.85% today

Updated 2026-04-30

Market cap

$1.07B

P/E ratio

—

P/S ratio

157.56x

EPS (TTM)

$-2.23

Dividend yield

—

52W range

$3 – $8

Volume

0.4M

Market cap

$1.07B

P/E ratio

—

P/S ratio

157.56x

EPS (TTM)

$-2.23

Dividend yield

—

52W range

$3 – $8

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$15.13

+194.93%

12-Month target

—

Intrinsic (DCF)

$16.65

Margin of safety

+62.82%

2 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 62.82% below intrinsic value

Risks

- Thin margins at 0.00%

- Negative free cash flow $-54.45M

- Revenue declining -89.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$12.18M	$17.48M	$9.20M	$4.48M	$6.76M
Net income	$-54.27M	$-110.43M	$-184.21M	$-340.16M	$-176.94M
EPS	—	—	—	—	$-2.23
Free cash flow	$-45.49M	$-82.15M	$-86.26M	$-101.22M	$-54.45M
Profit margin	-445.64%	-631.84%	-2,002.74%	-7,587.80%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IVA	$1.07B	21	2.7	2.5	6.7	5.0	+62.82%	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Inventiva Sa trades at $5.13. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $6.76M. Our DCF model estimates intrinsic value at $16.65.

Frequently asked questions

What is Inventiva Sa's stock price?

Inventiva Sa (IVA) trades at $5.13.

Is Inventiva Sa overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell). DCF value $16.65.

What is the price target of Inventiva Sa (IVA)?

The analyst target price is $15.13, representing +194.9% upside from the current price of $5.13.

What is the intrinsic value of Inventiva Sa (IVA)?

Based on our DCF model, intrinsic value is $16.65, a +62.8% margin of safety versus $5.13.

What is Inventiva Sa's revenue?

TTM revenue is $6.76M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio157.56x

ROE-1,643.00%

Beta0.95

50D MA$5.92

200D MA$5.12

Shares out0.21B

Float0.12B

Short ratio—

Avg volume0.4M

Performance

1 week-4.37%

1 month-9.59%

3 months+14.92%

YTD+17.63%

1 year—

3 years—

5 years—

Compare

IVA vs LLY →IVA vs JNJ →IVA vs ABBV →Stock screener →